MapLight (MPLT) Chief Discovery Officer Anatol Kreitzer Sells Shares

What Happened
Anatol Kreitzer, MapLight Therapeutics’ Chief Discovery Officer, sold a total of 36,284 shares in a series of open‑market transactions from July 15–17, 2026, generating roughly $1,345,893 in proceeds. Individual reported trades:

• 7/15/2026 — 5,545 shares @ $36.13 = $200,341
• 7/15/2026 — 4,510 shares @ $36.94 = $166,599
• 7/16/2026 — 7,464 shares @ $36.66 = $273,630
• 7/16/2026 — 1,592 shares @ $37.44 = $59,604
• 7/17/2026 — 2,833 shares @ $37.05 = $104,963
• 7/17/2026 — 14,140 shares @ $37.70 = $533,078
• 7/17/2026 — 200 shares @ $38.39 = $7,678

These were all sales (transaction code S). Sales are often routine; they do not necessarily signal negative views by the insider.

Key Details

• Dates: July 15–17, 2026. Form 4 filed July 20, 2026 (appears later than the typical 2 business‑day filing requirement).
• Total shares sold: 36,284; total proceeds: ≈ $1,345,893.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Notable footnotes: the filing indicates (a) a “sell to cover” to satisfy tax withholding obligations, (b) that several reported prices are weighted averages (sales executed across price ranges), and (c) at least one sale was executed under a Rule 10b5‑1 trading plan adopted Dec 24, 2025.
• Transaction types: S = Sale; F (in footnotes) indicates tax withholding / sell‑to‑cover for vested RSUs.

Context

• Sell‑to‑cover transactions (tax withholding) and sales under pre‑set 10b5‑1 plans are common and are typically considered routine rather than an immediate bearish signal.
• For retail investors, outright purchases by insiders are often more indicative of confidence than routine sales. This filing documents multiple open‑market sales totaling about $1.35M; interpretation should account for the tax and trading‑plan context and the late filing.

If you want, I can pull the exact ownership after the trades from the full Form 4 or highlight which trade(s) the 10b5‑1 and sell‑to‑cover footnotes specifically apply to.